Wednesday, October 1, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Truist Securities Analyst Reaffirms Hold Rating on Sunrun with Updated Price Target

Elaine Mendonca by Elaine Mendonca
February 26, 2024
in Breaking News
0
Finances-and-tech
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Truist Securities analyst Jordan Levy recently reaffirmed a Hold rating on Sunrun (NASDAQ: RUN) and adjusted the price target to $14 on February 26, 2024. This update comes after a previous downgrade from Buy to Hold with a price target of $12 on October 4, 2023. Back on May 9, 2023, Truist Securities had initially recommended a Buy for Sunrun before the subsequent adjustments.

RUN Stock Shows Positive Momentum on February 26, 2024: A Promising Sign for Investors

On February 26, 2024, Run stock (RUN) showed some positive momentum in its performance. Despite trading near the bottom of its 52-week range and below its 200-day simple moving average, the stock managed to see a slight increase in its price.

At the opening of the market, RUN was priced at $11.71, which was $0.19 lower than its previous close. However, throughout the trading day, the stock saw a price increase of $0.02, resulting in a 0.17% rise in its value since the market last closed.

While the increase may seem small, it is a positive sign for investors as it shows that there is some upward movement in the stock’s performance. This could be attributed to various factors such as positive news about the company, changes in market conditions, or investor sentiment.

It is important to note that even though the stock is trading near the bottom of its 52-week range, this does not necessarily mean that it is a bad investment. Investors should consider other factors such as the company’s financial health, growth prospects, and industry trends before making any investment decisions.

Overall, the slight increase in RUN stock on February 26, 2024, is a positive sign for investors. It will be interesting to see how the stock performs in the coming days and whether it can sustain this upward momentum.

Run Stock Performance Review: Flat Revenue, Improved Net Income, and Increased EPS on February 26, 2024

On February 26, 2024, Run stock experienced mixed performances based on the financial data provided by CNN Money. Total revenue for Run stood at $2.26 billion for the past year, remaining flat compared to the previous year. Similarly, total revenue for the last quarter was $516.59 million, also holding flat since the previous quarter.

In terms of net income, Run reported a net loss of $1.60 billion for the past year, representing a significant decrease of 1025.44% compared to the previous year. However, the net loss for the last quarter improved to $350.12 million, indicating a 67.26% increase from the previous quarter.

Earnings per share (EPS) for Run showed a similar trend. The EPS for the past year was -$7.41, reflecting a decrease of 1036.19% compared to the previous year. On the other hand, the EPS for the last quarter improved to -$1.60, showing a 67.43% increase from the previous quarter.

Overall, Run stock performances on February 26, 2024, demonstrated a mixed picture with flat total revenue, improved net income from the previous quarter, and an increase in earnings per share. Investors may want to closely monitor Run’s financial performance in the coming quarters to assess its long-term growth potential.

Tags: RUN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
MMM stock news

Analysts Bullish on AerCap Holdings with Positive Rating and Increased Price Target

Biotechnology Stock Bull Market

Title Request for Access to Google Docs Content

Healthcare cloud based

R1 RCM Stock Surges Following Lucrative Acquisition Offer

Recommended

Retail Market Capitalization

Minimum Order Value Policy for Discounts at Best Stocks

2 years ago

Cantor Fitzgerald Analyst Reaffirms Positive Stance on Udemy with 20 Price Target

2 years ago
Beauty Health Co Stock

Beauty Health Stock: A Tale of Conflicting Market Signals

1 month ago
Aldeyra Therapeutics Stock

Biotech Firm Aldeyra Therapeutics Gains Analyst Favor with Strong Growth Outlook

16 hours ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD Apple BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla Tilray TSLA Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

DroneShield Shares Maintain Extraordinary Growth Trajectory

XRP Approaches Critical Juncture Amid Conflicting Market Signals

Novo Nordisk Faces Market Pressure Amid Regulatory Milestones and Analyst Downgrade

Siemens Energy Shares Surge Amid Divergent Market Views

Bayer Shares Approach Critical 30 Euro Threshold

Rheinmetall Shares Approach €2,000 Milestone on Defense Surge

Trending

Hensoldt Stock
Defense & Aerospace

German Defense Giant Hensold Announces Billion-Euro Expansion Amid Unprecedented Orders

by Dieter Jaworski
September 30, 2025
0

Germany's security landscape is undergoing a fundamental transformation, with defense specialist Hensoldt at the epicenter of this...

Redcare Pharmacy Stock

Redcare Pharmacy Shares Plunge Following CFO’s Sudden Departure

September 30, 2025
Voestalpine Stock

Voestalpine Shares Face Critical Test at €30 Threshold

September 30, 2025
DroneShield Stock

DroneShield Shares Maintain Extraordinary Growth Trajectory

September 30, 2025
XRP Stock

XRP Approaches Critical Juncture Amid Conflicting Market Signals

September 30, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • German Defense Giant Hensold Announces Billion-Euro Expansion Amid Unprecedented Orders
  • Redcare Pharmacy Shares Plunge Following CFO’s Sudden Departure
  • Voestalpine Shares Face Critical Test at €30 Threshold

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com